OVID

2.2055.77%
ZZ

Zhong Zhong

Chief Scientific Officer

Dr. Zhong Zhong, Ph.D, has been Chief Scientific Officer at Ovid Therapeutics Inc. since June 2023. Dr. Zhong served as Senior Vice President of DNA Sciences at Generation Bio Co. until November 2022. Dr. Zhong started his career at Johnson & Johnson. He served as Vice President and Head of Gene Therapy at Generation Bio Co. since 2020. He served as Vice President of Biology at Wave Life Sciences from 2016 through 2019, he supported the development of an oligotherapeutics pipeline for central nervous system, ophthalmology, hepatic/metabolic and muscle diseases. Previously, at Vertex Pharmaceuticals, he established a research site in Shanghai before moving to Boston in 2015 to oversee external research and innovation projects. From 2008 to 2013, as part of GSK’s leadership team for neuroscience research, he established both platform functions and a stem cell discovery performance unit. He also led the GSK neuroinflammation R&D team, which delivered clinical candidates for several multiple sclerosis clinical studies. He started his career at J&J, developing cell assay technologies, as well as leading operations and research for the startup Cell & Molecular Technologies Inc through its acquisition and integration by Invitrogen (now Thermo Fisher Scientific).He earned a Ph.D. in Molecular Cell Biology from The Rockefeller University in New York. where he discovered Stat3 and Stat4. He completed his Postdoctoral Fellow in the laboratory of Dr. Richard Axel at Columbia University.

Positions